Interojo Inc. (KOSDAQ:119610)
20,300
+1,100 (5.73%)
May 20, 2026, 3:30 PM KST
Interojo Market Cap
Interojo has a market cap or net worth of 231.7 billion as of May 20, 2026. Its market cap has decreased by -44.30% in one year.
Market Cap
231.70B
Enterprise Value
254.69B
Revenue
118.44B
Ranking
n/a
PE Ratio
20.17
Stock Price
20,300.00
Market Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 231.70B, an increase of 423.16%. That is a compound annual growth rate of 11.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 231.70B | 26.80% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.16T |
| Celltrion | 38.25T |
| ALTEOGEN | 19.61T |
| Samsung Epis Holdings | 11.92T |
| Boditech Med | 227.25B |
| BNC KOREA | 223.31B |
| REYON Pharmaceutical | 222.48B |
| Chong Kun Dang Holdings | 218.51B |